Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells. 2014

Fermín E González, and Carolina Ortiz, and Montserrat Reyes, and Nicolás Dutzan, and Vyomesh Patel, and Cristián Pereda, and Maria A Gleisner, and Mercedes N López, and J Silvio Gutkind, and Flavio Salazar-Onfray
Millennium Institute on Immunology and Immunotherapy, University of Chile, Santiago, Chile; Department of Conservative Dentistry, Faculty of Dentistry, University of Chile, Santiago, Chile.

We have previously reported a novel method for the production of tumour-antigen-presenting cells (referred to as TAPCells) that are currently being used in cancer therapy, using an allogeneic melanoma-derived cell lysate (referred to as TRIMEL) as an antigen provider and activation factor. It was recently demonstrated that TAPCell-based immunotherapy induces T-cell-mediated immune responses resulting in improved long-term survival of stage IV melanoma patients. Clinically, dendritic cell (DC) migration from injected sites to lymph nodes is an important requirement for an effective anti-tumour immunization. This mobilization of DCs is mainly driven by the C-C chemokine receptor type 7 (CCR7), which is up-regulated on mature DCs. Using flow cytometry and immunohistochemistry, we investigated if TRIMEL was capable of inducing the expression of the CCR7 on TAPCells and enhancing their migration in vitro, as well as their in vivo relocation to lymph nodes in an ectopic xenograft animal model. Our results confirmed that TRIMEL induces a phenotypic maturation and increases the expression of surface CCR7 on melanoma patient-derived DCs, and also on the monocytic/macrophage cell line THP-1. Moreover, in vitro assays showed that TRIMEL-stimulated DCs and THP-1 cells were capable of migrating specifically in the presence of the CCR7 ligand CCL19. Finally, we demonstrated that TAPCells could migrate in vivo from the injection site into the draining lymph nodes. This work contributes to an increased understanding of the biology of DCs produced ex vivo allowing the design of new strategies for effective DC-based vaccines for treating aggressive melanomas.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002457 Cell Extracts Preparations of cell constituents or subcellular materials, isolates, or substances. Cell Extract,Extract, Cell,Extracts, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016513 Mice, SCID Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice. SCID Mice,SCID-hu Mice,Severe Combined Immunodeficient Mice,Immunodeficient Mice, Severe Combined,Mouse, SCID,Mouse, SCID-hu,Mice, SCID-hu,Mouse, SCID hu,SCID Mouse,SCID hu Mice,SCID-hu Mouse

Related Publications

Fermín E González, and Carolina Ortiz, and Montserrat Reyes, and Nicolás Dutzan, and Vyomesh Patel, and Cristián Pereda, and Maria A Gleisner, and Mercedes N López, and J Silvio Gutkind, and Flavio Salazar-Onfray
December 2014, Nature medicine,
Fermín E González, and Carolina Ortiz, and Montserrat Reyes, and Nicolás Dutzan, and Vyomesh Patel, and Cristián Pereda, and Maria A Gleisner, and Mercedes N López, and J Silvio Gutkind, and Flavio Salazar-Onfray
March 2014, Seminars in immunopathology,
Fermín E González, and Carolina Ortiz, and Montserrat Reyes, and Nicolás Dutzan, and Vyomesh Patel, and Cristián Pereda, and Maria A Gleisner, and Mercedes N López, and J Silvio Gutkind, and Flavio Salazar-Onfray
January 2012, Journal of immunology (Baltimore, Md. : 1950),
Fermín E González, and Carolina Ortiz, and Montserrat Reyes, and Nicolás Dutzan, and Vyomesh Patel, and Cristián Pereda, and Maria A Gleisner, and Mercedes N López, and J Silvio Gutkind, and Flavio Salazar-Onfray
May 2016, Experimental eye research,
Fermín E González, and Carolina Ortiz, and Montserrat Reyes, and Nicolás Dutzan, and Vyomesh Patel, and Cristián Pereda, and Maria A Gleisner, and Mercedes N López, and J Silvio Gutkind, and Flavio Salazar-Onfray
October 2021, Cancers,
Fermín E González, and Carolina Ortiz, and Montserrat Reyes, and Nicolás Dutzan, and Vyomesh Patel, and Cristián Pereda, and Maria A Gleisner, and Mercedes N López, and J Silvio Gutkind, and Flavio Salazar-Onfray
September 2006, European journal of immunology,
Fermín E González, and Carolina Ortiz, and Montserrat Reyes, and Nicolás Dutzan, and Vyomesh Patel, and Cristián Pereda, and Maria A Gleisner, and Mercedes N López, and J Silvio Gutkind, and Flavio Salazar-Onfray
February 1992, Immunology,
Fermín E González, and Carolina Ortiz, and Montserrat Reyes, and Nicolás Dutzan, and Vyomesh Patel, and Cristián Pereda, and Maria A Gleisner, and Mercedes N López, and J Silvio Gutkind, and Flavio Salazar-Onfray
July 2010, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
Fermín E González, and Carolina Ortiz, and Montserrat Reyes, and Nicolás Dutzan, and Vyomesh Patel, and Cristián Pereda, and Maria A Gleisner, and Mercedes N López, and J Silvio Gutkind, and Flavio Salazar-Onfray
March 1987, Cancer research,
Fermín E González, and Carolina Ortiz, and Montserrat Reyes, and Nicolás Dutzan, and Vyomesh Patel, and Cristián Pereda, and Maria A Gleisner, and Mercedes N López, and J Silvio Gutkind, and Flavio Salazar-Onfray
January 2009, Handbook of experimental pharmacology,
Copied contents to your clipboard!